EA200900662A1 - Лечение синдрома "сухого глаза" с помощью тестостерона и прогестагена - Google Patents
Лечение синдрома "сухого глаза" с помощью тестостерона и прогестагенаInfo
- Publication number
- EA200900662A1 EA200900662A1 EA200900662A EA200900662A EA200900662A1 EA 200900662 A1 EA200900662 A1 EA 200900662A1 EA 200900662 A EA200900662 A EA 200900662A EA 200900662 A EA200900662 A EA 200900662A EA 200900662 A1 EA200900662 A1 EA 200900662A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- progestagene
- testosterone
- treatment
- dry eye
- eye syndrome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Eyeglasses (AREA)
Abstract
Настоящее изобретение относится к композиции и способам лечения заболеваний глаз с помощью композиции, содержащей терапевтически эффективное количество прогестагена, терапевтически эффективное количество прогестагена и фармацевтически приемлемый носитель, причем композиция наносится на пальпебральную часть глаза и/или на поверхность глаза.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/634,347 US20080132475A1 (en) | 2006-12-05 | 2006-12-05 | Treatment for dry eye |
PCT/US2007/086517 WO2008070728A2 (en) | 2006-12-05 | 2007-12-05 | Treatment for dry eye using testosterone and progestagen |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200900662A1 true EA200900662A1 (ru) | 2009-12-30 |
Family
ID=39476533
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900662A EA200900662A1 (ru) | 2006-12-05 | 2007-12-05 | Лечение синдрома "сухого глаза" с помощью тестостерона и прогестагена |
EA200900663A EA200900663A1 (ru) | 2006-12-05 | 2007-12-05 | Лечение синдрома "сухого глаза" |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900663A EA200900663A1 (ru) | 2006-12-05 | 2007-12-05 | Лечение синдрома "сухого глаза" |
Country Status (12)
Country | Link |
---|---|
US (3) | US20080132475A1 (ru) |
EP (2) | EP2101785A4 (ru) |
JP (2) | JP2010511729A (ru) |
KR (2) | KR20090104813A (ru) |
CN (2) | CN101636165A (ru) |
AU (1) | AU2009202711A1 (ru) |
BR (2) | BRPI0720172A2 (ru) |
CA (2) | CA2671698A1 (ru) |
EA (2) | EA200900662A1 (ru) |
IL (1) | IL199094A0 (ru) |
MX (2) | MX2009005993A (ru) |
WO (2) | WO2008070728A2 (ru) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10105441B2 (en) * | 2007-08-16 | 2018-10-23 | The Schepens Eye Research Institute, Inc. | Method for inhibiting or reducing dry eye disease by IL-1Ra |
US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
EP2320912B1 (en) * | 2008-08-05 | 2015-01-14 | University College Cork-National University of Ireland, Cork | Treatment of retinal degeneration |
MX344046B (es) | 2011-01-26 | 2016-12-02 | Allergan Inc | Composicion de androgeno para tratar una afeccion oftalmica. |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
MX362185B (es) | 2012-07-27 | 2019-01-08 | Glia Llc | Composiciones y tratamiento para enfermedades y trastornos del ojo. |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9682032B2 (en) * | 2013-03-15 | 2017-06-20 | Glia, Llc | Cranial delivery of pharmaceuticals |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3174542A4 (en) | 2014-07-29 | 2018-01-03 | TherapeuticsMD, Inc. | Transdermal cream |
MX2017012708A (es) * | 2015-04-03 | 2018-01-09 | Santen Pharmaceutical Co Ltd | Agente terapeutico para ojo seco que comprende nandrolona o ester del mismo o metenolona o ester del mismo como un ingrediente activo. |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
CN110072523A (zh) | 2016-09-07 | 2019-07-30 | 格利亚有限责任公司 | 通过脑神经的药理皮肤激活来治疗与神经退行性病症相关的症状 |
TW202131927A (zh) * | 2019-11-13 | 2021-09-01 | 美商葛莉亞有限責任公司 | 睾固酮組合物 |
WO2023107796A1 (en) * | 2021-12-11 | 2023-06-15 | The Regents Of The University Of California | Ophthalmic formulations for macular degeneration |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
JPS59184135A (ja) * | 1983-04-04 | 1984-10-19 | Teijin Ltd | グリセリンピログルタミン酸エステル類を含有する医薬品組成物 |
US4617299A (en) * | 1983-12-19 | 1986-10-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
DE3514724A1 (de) * | 1985-04-24 | 1986-10-30 | Albin F. Dr. 4200 Oberhausen Jereb | Salbe zur verbeugung und behandlung von augen- und hauterkrankungen |
US4914088A (en) * | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
USRE34578E (en) * | 1990-05-07 | 1994-04-05 | Lubkin; Virginia | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
ZA912797B (en) * | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
US5688765A (en) * | 1992-04-21 | 1997-11-18 | The Schepens Eye Research Institute, Inc. | Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β |
DE69326836T2 (de) * | 1992-04-21 | 2000-02-24 | The Schepens Eye Research Institute, Inc. | Androgentherapie am auge beim sjögrensyndrom |
US5958912A (en) * | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
US6107289A (en) * | 1992-04-21 | 2000-08-22 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
US5366739A (en) * | 1992-08-06 | 1994-11-22 | Deo Corporation | Method of ophthalmic drug delivery |
DE69328368T2 (de) * | 1992-08-28 | 2000-08-10 | Pharmos Corp., New York | Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge |
WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
JP2000515523A (ja) * | 1996-07-22 | 2000-11-21 | ザ・ビクトリア・ユニバーシティ・オブ・マンチェスター | 創傷および線維性障害の治療における性ステロイド機能モジュレーターの使用 |
AU735944B2 (en) * | 1997-02-28 | 2001-07-19 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of testosterone |
US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
FR2774587B1 (fr) * | 1998-02-09 | 2000-03-10 | Oreal | Utilisation d'une microdispersion de cire dans une composition cosmetique ou dermatologique |
US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
PE20010404A1 (es) * | 1999-06-11 | 2001-04-09 | Watson Pharmaceuticals Inc | Combinacion de esteroides androgenicos no orales y compuestos estrogenicos y su uso en mujeres |
US6569903B2 (en) * | 1999-12-07 | 2003-05-27 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic compositions |
US6630175B1 (en) * | 2000-06-29 | 2003-10-07 | Johnson & Johnson Consumer Companies, Inc. | Method of reducing eye irritation |
WO2002055020A2 (en) * | 2000-12-11 | 2002-07-18 | Testocreme Llc | Topical testosterone formulations and associated methods |
US6659985B2 (en) * | 2002-01-30 | 2003-12-09 | Southern College Of Optometry | Method to use transdermal administration of androgens to the adnexa of the eye |
WO2004045510A2 (en) * | 2002-11-15 | 2004-06-03 | Panaseca, Inc. | Methods and compositions for alleviating dry eyes |
US20060111318A1 (en) * | 2003-04-18 | 2006-05-25 | Advanced Medicine Research Institute | Agent for treating eye diseases |
US6984628B2 (en) * | 2003-07-15 | 2006-01-10 | Allergan, Inc. | Ophthalmic compositions comprising trefoil factor family peptides |
US7960350B2 (en) * | 2003-10-24 | 2011-06-14 | Ader Enterprises, Inc. | Composition and method for the treatment of eye disease |
US20050202097A1 (en) * | 2004-03-12 | 2005-09-15 | Melbj Holdings, Llc, Florida | Lubricant for the ocular surface |
US20050234018A1 (en) * | 2004-04-15 | 2005-10-20 | Allergan, Inc. | Drug delivery to the back of the eye |
US20060110428A1 (en) * | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
US20060258698A1 (en) * | 2005-02-09 | 2006-11-16 | Sreenivasu Mudumba | Liquid formulations for treatment of diseases or conditions |
US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
-
2006
- 2006-12-05 US US11/634,347 patent/US20080132475A1/en not_active Abandoned
-
2007
- 2007-12-05 CA CA002671698A patent/CA2671698A1/en not_active Abandoned
- 2007-12-05 BR BRPI0720172-9A patent/BRPI0720172A2/pt not_active IP Right Cessation
- 2007-12-05 WO PCT/US2007/086517 patent/WO2008070728A2/en active Application Filing
- 2007-12-05 EP EP07865242A patent/EP2101785A4/en not_active Withdrawn
- 2007-12-05 EA EA200900662A patent/EA200900662A1/ru unknown
- 2007-12-05 EP EP07865244A patent/EP2124958A4/en not_active Withdrawn
- 2007-12-05 MX MX2009005993A patent/MX2009005993A/es not_active Application Discontinuation
- 2007-12-05 KR KR1020097013348A patent/KR20090104813A/ko not_active Application Discontinuation
- 2007-12-05 EA EA200900663A patent/EA200900663A1/ru unknown
- 2007-12-05 MX MX2009005994A patent/MX2009005994A/es not_active Application Discontinuation
- 2007-12-05 CN CN200780049245A patent/CN101636165A/zh active Pending
- 2007-12-05 JP JP2009540451A patent/JP2010511729A/ja active Pending
- 2007-12-05 JP JP2009540453A patent/JP2010511730A/ja active Pending
- 2007-12-05 WO PCT/US2007/086515 patent/WO2008070726A2/en active Application Filing
- 2007-12-05 BR BRPI0719918-0A2A patent/BRPI0719918A2/pt not_active IP Right Cessation
- 2007-12-05 KR KR1020097013349A patent/KR20090104814A/ko not_active Application Discontinuation
- 2007-12-05 CN CN200780049235A patent/CN101636164A/zh active Pending
- 2007-12-05 CA CA002671769A patent/CA2671769A1/en not_active Abandoned
-
2009
- 2009-06-02 IL IL199094A patent/IL199094A0/en unknown
- 2009-07-03 AU AU2009202711A patent/AU2009202711A1/en not_active Abandoned
-
2013
- 2013-12-23 US US14/139,243 patent/US20140113889A1/en not_active Abandoned
-
2020
- 2020-02-18 US US16/793,581 patent/US20210008079A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008070726A2 (en) | 2008-06-12 |
EA200900663A1 (ru) | 2009-12-30 |
WO2008070726A3 (en) | 2008-08-21 |
EP2101785A2 (en) | 2009-09-23 |
MX2009005994A (es) | 2009-12-14 |
AU2009202711A1 (en) | 2009-07-23 |
BRPI0719918A2 (pt) | 2014-03-04 |
WO2008070728A2 (en) | 2008-06-12 |
US20080132475A1 (en) | 2008-06-05 |
IL199094A0 (en) | 2010-03-28 |
US20210008079A1 (en) | 2021-01-14 |
KR20090104813A (ko) | 2009-10-06 |
EP2101785A4 (en) | 2009-12-30 |
JP2010511729A (ja) | 2010-04-15 |
CA2671698A1 (en) | 2008-06-12 |
CN101636165A (zh) | 2010-01-27 |
CN101636164A (zh) | 2010-01-27 |
MX2009005993A (es) | 2009-12-14 |
EP2124958A4 (en) | 2009-12-30 |
BRPI0720172A2 (pt) | 2014-01-07 |
WO2008070728A3 (en) | 2008-08-07 |
KR20090104814A (ko) | 2009-10-06 |
EP2124958A2 (en) | 2009-12-02 |
US20140113889A1 (en) | 2014-04-24 |
CA2671769A1 (en) | 2008-06-12 |
JP2010511730A (ja) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900662A1 (ru) | Лечение синдрома "сухого глаза" с помощью тестостерона и прогестагена | |
WO2008070593A3 (en) | Variant target binding agents and uses thereof | |
EA200601746A1 (ru) | Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс" | |
EA200601648A1 (ru) | Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
BRPI0813699A2 (pt) | Formulações de proteína de fusão glp-1-fc | |
IL192181A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
EP2628486A3 (en) | Method for treating bone fracture with anti-sclerostin antibodies | |
BRPI0506970A (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
MXPA05013733A (es) | 2-aminobenzotiazoles como agonistas inversos del receptor de cb1. | |
WO2008075376A8 (en) | Polymorphic forms of bortezomib and process for their preparation | |
WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
EA200870093A1 (ru) | Применение производных бензоконденсированного гетероциклического сульфамида для лечения ожирения | |
ATE384058T1 (de) | Thiazolderivate | |
MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
MX2010007584A (es) | Inhibidores de proteina cinasa y uso de los mismos. | |
MX2011012015A (es) | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. | |
MX2012012355A (es) | Composiciones organicas para tratar enfermedades relacionadas con beta-enac. | |
DOP2011000055A (es) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos | |
WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
EA200700772A1 (ru) | Аналоги полиаминов в качестве терапевтических средств для глазных заболеваний | |
NZ597866A (en) | Therapeutic lactams | |
WO2006101909A3 (en) | Combination therapy for treating or preventing diseases | |
NZ595271A (en) | Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases | |
WO2007095609A3 (en) | Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder |